Big Pharma spent almost as much on shareholders as on R&D

THE world’s 20 biggest pharmaceutical companies handed nearly as much money to shareholders and executives as they claim to have spent on developing new vaccines and medicines during the Covid-19 pandemic, according to new figures revealed by the People’s Vaccine Alliance at the World Health Summit in Berlin.